The above studies have shown that the overexpression of MMP14, ITGA2 and THBS2 promotes pancreatic cancer occurrence and development and indicate that they possess the ability to become therapeutic targets of PDAC. This evidence concerns the gene ITGA2 and pancreatic neoplasm.